Sliding Scale Insulin Protocol for Diabetic Patients
Sliding scale insulin alone is strongly discouraged for managing diabetes in hospitalized patients as it is ineffective and should be replaced with basal-bolus insulin regimens. 1, 2
Recommended Insulin Management Approach
Basal-Bolus Insulin Regimen (Preferred Approach)
Initial Dosing:
Basal Insulin:
Bolus (Prandial) Insulin:
Correction Dose Protocol
For blood glucose values above target, add rapid-acting insulin as follows:
250 mg/dL: Add 2 units
350 mg/dL: Add 4 units 2
Monitoring Protocol
Hospitalized Patients
- For patients who are eating: Monitor glucose before meals 2
- For patients not eating: Monitor every 4-6 hours 2
- For patients on continuous NG feeding: Monitor every 4-6 hours 2
- For patients on intermittent NG feeding: Monitor before meals and at bedtime 2
- For patients on IV insulin: Monitor every 30 minutes to 2 hours 2
Target Blood Glucose Range
- General hospitalized patients: 140-180 mg/dL 2
- Older adults: 90-150 mg/dL (less aggressive targets) 2
Hypoglycemia Management Protocol
- Define hypoglycemia as blood glucose <70 mg/dL 2
- For mild-moderate hypoglycemia (54-70 mg/dL) in conscious patients:
- Administer 15-20g oral carbohydrate
- Recheck blood glucose after 15 minutes 2
- For severe hypoglycemia (<54 mg/dL) or unconscious patients:
- Administer IV dextrose 25g (50 mL of 50% solution) or
- Glucagon 1mg IM/SC if IV access is not available 2
Special Considerations
Transitioning from IV to Subcutaneous Insulin
- Administer subcutaneous basal insulin 2-4 hours before discontinuing IV infusion 1
- Convert to basal insulin at 60-80% of the daily infusion dose 1
Renal Impairment
- Reduce insulin doses by 20-25% 2
Pre-Surgery Management
- Consider reducing evening insulin dose by 25% before surgery 2
Why Sliding Scale Alone Is Discouraged
Sliding scale insulin as monotherapy is strongly discouraged because:
- It is reactive rather than preventive (dosing given in response to elevated glucose) 1
- It does not account for basal insulin requirements 1
- It results in poor glycemic control with persistent hyperglycemia 3
- Randomized controlled trials have shown that basal-bolus treatment improves glycemic control and reduces hospital complications compared to sliding scale insulin regimens 1
The American Diabetes Association, American College of Clinical Endocrinologists, and other major guidelines consistently recommend against using sliding scale insulin alone for managing diabetes in hospitalized patients 1, 2.